Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Petros Pharmaceuticals has developed a proprietary AI-driven SaaS/SaMD platform to facilitate prescription-to-over-the-counter (Rx-to-OTC) drug transitions. Recent pivotal studies demonstrated high consumer comprehension of critical objectives required by FDA guidelines for OTC switches. The company has completed eight supporting research studies and achieved positive results in application comprehension trials with over 400 participants. No direct clinical efficacy data on therapeutics since the focus is on enabling technology rather than specific drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Petroda.